profile icon
Ms

Janni Christensen

Honorary
Medical Biology (w.e.h.i.)
plasmodium
ama1
life cycle stages
5.1 pharmaceuticals
merozoites
virology
plasmepsin x
mice
prevention
Janni Christensen's Profile Picture
Ms

Janni Christensen

 
Division
Medicine, Dentistry and Health Sciences
Janni Christensen's Profile Picture
Ms

Janni Christensen

 
Print
Janni's  Short Profile
 

Find out more about Janni Christensen's experience

Janni Christensen's highlights

Scholarly Works

Displaying the 1 most recent scholarly work from 1 for Janni Christensen.

Scholarly works icon

Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle

Paola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, Tony Triglia, Anna Ngo, Ryan WJ Steel, Marissa Vavrek, Janni Christensen, Julie Healer, Christopher Boyce, Zhuyan Guo, Mengwei Hu, Tanweer Khan, Nicholas Murgolo, Lianyun Zhao, Jocelyn Sietsma Penington, Kitsanapong Reaksudsan, Kate Jarman, Melanie H Dietrich, Lachlan Richardson, et al.

Journal article  |  2020  |  CELL HOST & MICROBE

Artemisin combination therapy (ACT) is the main treatment option for malaria, which is caused by the intracellular parasite Plasmo..

1

Scholarly Works

Keyword Analysis

Clinical Health
Medical Microbiology

Credentials

Positions

Honorary

Medical Biology (w.e.h.i.)